$8B Philly Risperdal Verdict Ripe For Reduction, Experts Say
After a Philadelphia jury walloped a Johnson & Johnson unit this week with $8 billion in punitive damages in a first-of-its-kind trial over the antipsychotic drug Risperdal, experts say they expect...To view the full article, register now.
Already a subscriber? Click here to view full article